Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer

NCT03237572 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Low rate of enrollment

Conditions

Breast Cancer

Interventions

DRUG: Pembrolizumab
DEVICE: High-intensity focused ultrasound (HIFU)

Sponsor

Patrick Dillon, MD